UMIN-CTR Clinical Trial

Unique ID issued by UMIN C000000309
Receipt number R000000399
Scientific Title Japan Morning Surge -1 study
Date of disclosure of the study information 2006/01/20
Last modified on 2006/01/19 19:00:57

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Japan Morning Surge -1 study

Acronym

JMS1 study

Scientific Title

Japan Morning Surge -1 study

Scientific Title:Acronym

JMS1 study

Region

Japan


Condition

Condition

Hypertensive outpatiens

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Morning blood pressure is reported to be more closely related to hypertensive organ damage such as left ventricular mass index, microalbuminuria and silent cerebral infarcts, than blood pressure at other times of the day. Morning blood pressure may play an important role in pathogenesis of hypertensive target organ damage. Increased sympathetic nerve activity is reported to be one of the mechanisms of morning hypertension; however, there are no available data that show whether strict home blood pressure control, especially in the morning period can reduce target organ damage.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Brain natriuretic peptide (BNP)
Urinary albumin excretion /creatinine ratio (UAR)

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking


Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Doxazosin

Interventions/Control_2

Doxazosin, beta blocker

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1.Hypertensive outpatients with uncontrolled morning systolic BP (>135 mmHg) and antihypertensive medication status for 3 months.

Key exclusion criteria

1. History of heart failure
2. Orthostatic hypotension
3. Dementia
4. Malignancy
5. Chronic inflammatory disease
6. Users of alfa blocker or beta blocker.
7. Atrial fibrillation.
8. Judged inappropriate for this study by the physicians

Target sample size

600


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kazuomi Kario

Organization

Jichi Medical University School of Medicine

Division name

Division of Cardiovascular Medicine

Zip code


Address

3311-1, Yakushiji, Shimotsuke, Tochigi, Japan

TEL

0285-58-7344

Email



Public contact

Name of contact person

1st name
Middle name
Last name

Organization

apan Morning Surge-1 study group

Division name

Division of Cardiovascular Medicine, Jichi Medical University School of Medicine

Zip code


Address


TEL


Homepage URL


Email



Sponsor or person

Institute

Division of Cardiovascular Medicine, Jichi Medical University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

The Japan Heart Foundation

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2006 Year 01 Month 20 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2003 Year 06 Month 30 Day

Date of IRB


Anticipated trial start date

2003 Year 08 Month 01 Day

Last follow-up date

2005 Year 08 Month 01 Day

Date of closure to data entry

2005 Year 09 Month 01 Day

Date trial data considered complete

2005 Year 10 Month 01 Day

Date analysis concluded

2006 Year 01 Month 01 Day


Other

Other related information



Management information

Registered date

2006 Year 01 Month 19 Day

Last modified on

2006 Year 01 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000000399


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name